Hammerhead ribozyme design and application

被引:51
作者
Amarzguioui, M [1 ]
Prydz, H [1 ]
机构
[1] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway
关键词
hammerhead; ribozyme; ribozyme stability; ribozyme design; flanking arms; oligonucleotide facilitators; target selection; cellular delivery;
D O I
10.1007/s000180050247
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emerging knowledge about RNA-based enzymes has already had great impact on our concept of evolutionary history, making the 'RNA world' more likely. It may well have an equally important impact on the diagnostic and therapeutic practices of human and veterinary medicine in the next decade. We are not quite there yet. This review addresses the design and application of hammerhead ribozymes, two aspects of a conserved,and most commonly studied and used enzymatically active entity among the RNA enzymes. The emerging picture is one of great diversity. There is at this stage no general cell model nor a clearly preferable ribozyme structure. Each and every cell line (and tissue) may be unique in that they vary with respect to structural requirements for optimal uptake, activity and stability of ribozymes. We may have seen only the tip of the iceberg when it comes to RNA-based enzymes and their roles in biology and medicine.
引用
收藏
页码:1175 / 1202
页数:28
相关论文
共 257 条
[61]   IMPORTANCE OF SPECIFIC ADENOSINE N(7)-NITROGENS FOR EFFICIENT CLEAVAGE BY A HAMMERHEAD RIBOZYME - A MODEL FOR MAGNESIUM BINDING [J].
FU, DJ ;
MCLAUGHLIN, LW .
BIOCHEMISTRY, 1992, 31 (45) :10941-10949
[62]   USE OF A HYBRID VACCINIA VIRUS-T7 RNA-POLYMERASE SYSTEM FOR EXPRESSION OF TARGET GENES [J].
FUERST, TR ;
EARL, PL ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (07) :2538-2544
[63]   EUKARYOTIC TRANSIENT-EXPRESSION SYSTEM BASED ON RECOMBINANT VACCINIA VIRUS THAT SYNTHESIZES BACTERIOPHAGE-T7 RNA-POLYMERASE [J].
FUERST, TR ;
NILES, EG ;
STUDIER, FW ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8122-8126
[64]  
Funato T, 1997, IN VIVO, V11, P217
[65]  
FUNATO T, 1992, ADV ENZYME REGUL, V32, P195
[66]   AN INTERACTIVE FRAMEWORK FOR RNA SECONDARY STRUCTURE PREDICTION WITH A DYNAMICAL TREATMENT OF CONSTRAINTS [J].
GASPIN, C ;
WESTHOF, E .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (02) :163-174
[67]   Efficient hammerhead ribozymes targeted to the polycistronic Sendai virus P/C mRNA - Structure-function relationships [J].
Gavin, DK ;
Gupta, KC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1461-1472
[68]   Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: Cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect [J].
Gebhard, JR ;
Perry, CM ;
Mahadeviah, S ;
Whitton, JL .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (01) :3-11
[69]   Multigene antiviral vectors inhibit diverse human immunodeficiency virus type I clades [J].
Gervaix, A ;
Li, XQ ;
Kraus, G ;
WongStaal, F .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3048-3053
[70]   Expression of small, therapeutic RNAs in human cell nuclei [J].
Good, PD ;
Krikos, AJ ;
Li, SXL ;
Bertrand, E ;
Lee, NS ;
Giver, L ;
Ellington, A ;
Zaia, JA ;
Rossi, JJ ;
Engelke, DR .
GENE THERAPY, 1997, 4 (01) :45-54